Skip to main content
  1. Market Insights
  2. Health
  3. Mental Health

Psychotic Disorders - Pakistan

Pakistan
  • Revenue in the Psychotic Disorders market is projected to reach US$31.26m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.79%, resulting in a market volume of US$32.52m by 2029.
  • In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
  • In relation to total population figures, per person revenues of US$18.47 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

In-Scope

  • Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Out-Of-Scope

  • Psychotherapy
  • Talk therapy
  • Herbal medicines
  • Digital health apps
  • Deep Brain Stimulation (DBS)
Psychotic Disorders: market data & analysis - Cover

Market Insights report

Psychotic Disorders: market data & analysis

Study Details

    Revenue

    Notes: Data was converted from local currencies using average exchange rates of the respective year.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Patients

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Analyst Opinion

    The Psychotic Disorders market in Pakistan is experiencing significant growth due to a variety of factors.

    Customer preferences:
    In Pakistan, there is an increasing awareness and recognition of mental health issues, including psychotic disorders. This has led to a growing demand for effective treatments and therapies. Customers are seeking out medications and therapies that can help manage symptoms and improve quality of life. Additionally, there is a preference for treatments that are affordable and easily accessible.

    Trends in the market:
    One of the key trends in the Psychotic Disorders market in Pakistan is the increasing availability and use of antipsychotic medications. These medications are commonly prescribed to manage symptoms such as hallucinations, delusions, and disordered thinking. The market is seeing a rise in the number of pharmaceutical companies offering antipsychotic medications, as well as an increase in the availability of generic versions of these drugs. This has made treatment more affordable and accessible for patients.Another trend in the market is the growing adoption of psychotherapy as a complementary treatment for psychotic disorders. Psychotherapy, such as cognitive behavioral therapy, can help individuals manage their symptoms and improve their overall well-being. There is an increasing number of mental health professionals in Pakistan who are trained in providing psychotherapy for psychotic disorders, and this has contributed to the growing popularity of this treatment option.

    Local special circumstances:
    Pakistan has a large population, and mental health issues, including psychotic disorders, are prevalent. The country has a shortage of mental health professionals, which has led to a significant treatment gap. However, there has been a push to address this issue, with the government and non-governmental organizations working to improve access to mental health services. This includes initiatives to train more mental health professionals and increase the availability of mental health clinics and hospitals.

    Underlying macroeconomic factors:
    Pakistan has been experiencing economic growth in recent years, which has led to an increase in healthcare spending. This has benefited the Psychotic Disorders market, as more resources are being allocated to mental health services and treatments. Additionally, the government has recognized the importance of addressing mental health issues and has implemented policies to support the development of the mental health sector.In conclusion, the Psychotic Disorders market in Pakistan is growing due to increasing customer preferences for effective and accessible treatments, as well as the availability of antipsychotic medications and the adoption of psychotherapy. Special circumstances, such as the shortage of mental health professionals, are being addressed through government and non-governmental initiatives. The underlying macroeconomic factors, including economic growth and government support, are also contributing to the development of the market.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

    Modeling approach / Market size:

    Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

    Additional Notes:

    The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

    Health

    Access more Market Insights on Health topics with our featured report

    Psychotic Disorders: market data & analysis - BackgroundPsychotic Disorders: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    U.S. Mental Health Issues - Statistics & Facts

    Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.